Group 1 - The core point of the news is that Langxin Group's stock price dropped by 5.01% to 18.02 CNY per share, with a trading volume of 819 million CNY and a turnover rate of 4.20%, resulting in a total market capitalization of 19.43 billion CNY [1] - Langxin Technology Group Co., Ltd. is located in Wuxi, Jiangsu Province, and was established on May 7, 2003, with its listing date on August 1, 2017 [1] - The company's main business involves information technology and services in the public utility sector, as well as home internet business, technology research and development, system construction, and business operations [1] Group 2 - According to data, Huatai Baoxing Fund has one fund heavily invested in Langxin Group, specifically the Huatai Baoxing Kairui One-Year Holding Mixed Fund A (018250), which held 14,100 shares, accounting for 2.43% of the fund's net value, making it the fourth-largest holding [2] - The fund was established on May 23, 2023, with a latest scale of 11.31 million CNY, and has a year-to-date return of 1.09%, ranking 7263 out of 8847 in its category [2] - The fund has experienced a loss of 1.78% over the past year, ranking 8044 out of 8094, and a cumulative loss of 1.27% since its inception [2] Group 3 - The fund manager of Huatai Baoxing Kairui One-Year Holding Mixed Fund A is Zhou Yongmei, who has a tenure of 7 years and 347 days, with the fund's total asset scale at 7.89 billion CNY and a best return of 47.57% during her tenure [3] - The co-manager, Huang Junqing, has a tenure of 254 days, with a total asset scale of 77.35 million CNY and a best return of 12.26% during his tenure [3]

Core Viewpoint - Huatai Baoxing Fund Company exhibits a common issue among insurance-related public funds, being more proficient in fixed income business while relying heavily on it, resulting in weaker equity business and difficulties in expansion [1][2] Group 1: Company Overview - Huatai Baoxing Fund was established on July 26, 2016, initiated and controlled by Huatai Insurance Group, with its registered location in Shanghai [3] - As of October 25 last year, the China Securities Regulatory Commission approved Ande Co., Ltd. as the actual controller of Huatai Baoxing Fund, marking its transition to a foreign-funded public fund company [3] Group 2: Fund Performance and Structure - As of the end of Q3 this year, Huatai Baoxing Fund managed a total of 34 products with a combined management scale of 67.707 billion yuan, ranking 76th among peers [1] - The company’s management scale remained below 40 billion yuan until mid-2024, but reached 46.7 billion yuan by the end of Q3 2024, and surpassed 50 billion yuan by the end of 2024, reaching 51.9 billion yuan [1] - Fixed income products dominate the product structure, significantly contributing to the company's recent scale growth, with bond fund sizes increasing from below 30 billion yuan until mid-2024 to 57.446 billion yuan by mid-2024 [1] Group 3: Equity Business Challenges - The equity business of Huatai Baoxing Fund has been weak, with the number of stock funds remaining at one until 2025, and its scale shrinking from 475 million yuan at the end of 2021 to 91 million yuan [2] - The recent establishment of two new equity funds in May 2024 has led to a significant increase in stock fund scale, approaching 400 million yuan [2] - The performance of equity funds has been poor, with the Huatai Baoxing Health Consumption A fund showing negative returns over various time frames, underperforming its benchmark by at least 25 percentage points since its inception [2]